News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Perry Andrew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Sold 355 shares
@ $2.4537, valued at
$871.1 |
|
| 05/12/2023 |
4
| Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 35,000 shares
@ $0 |
|
| 01/05/2023 |
4
| Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 16,100 shares
@ $0
Sold 820 shares
@ $5.5756, valued at
$4.6k
Granted 32,100 options to buy
@ $5.73, valued at
$183.9k
|
|
| 01/05/2022 |
4
| Perry Andrew (Chief Commercial Officer) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 6,000 shares
@ $0
Granted 26,500 options to buy
@ $10.69, valued at
$283.3k
|
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|